Chengyu Prince

732 total citations
20 papers, 540 citations indexed

About

Chengyu Prince is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Chengyu Prince has authored 20 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Chengyu Prince's work include Immune Cell Function and Interaction (8 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Chengyu Prince is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Chengyu Prince collaborates with scholars based in United States, Russia and Germany. Chengyu Prince's co-authors include Wenli Wang, Matthew J. Pollman, Yongshan Mou, Donald L. Durden, Peter K. Vogt, Gerene M. Denning, Alexandre Holthausen Campos, Xing Hu, Shanmuganathan Chandrakasan and Guiying Cui and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Chengyu Prince

19 papers receiving 536 citations

Peers

Countries citing papers authored by Chengyu Prince

Since Specialization

Citations

This map shows the geographic impact of Chengyu Prince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyu Prince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyu Prince more than expected).

Fields of papers citing papers by Chengyu Prince

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyu Prince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyu Prince. The network helps show where Chengyu Prince may publish in the future.

Co-authorship network of co-authors of Chengyu Prince

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyu Prince. A scholar is included among the top collaborators of Chengyu Prince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyu Prince. Chengyu Prince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systemic T-cell activation and IFN-γ activity in indeterminate severe hepatitis are reminiscent of hemophagocytic lymphohistiocytosis: Implications for T-cell– and IFN-γ–directed therapies 2024 ·Journal of Allergy and Clinical Immunology ·Thinh H. Nguyen, Prakash Satwani, Deepak Kumar, Urvi Kapoor, (unknown), Chengyu Prince, (unknown), (unknown), Mercedes Martínez, (unknown), Rebecca Marsh, Helen Remotti, Ladan Fazlollahi, (unknown), René Romero, Shanmuganathan Chandrakasan	2
2	Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis 2023 ·Blood ·(unknown), (unknown), Suresh Venkateswaran, Deepak Kumar, Chengyu Prince, Vaunita Parihar, (unknown), Edmund K. Waller, Subra Kugathasan, Michael Briones, (unknown), Curtis J. Henry, Sampath Prahalad, Shanmuganathan Chandrakasan	3
3	Limitations of Bu/Flu-based preparative regimen in CTLA-4 haploinsufficiency to achieving disease phenotype correction 2023 ·Clinical Immunology ·(unknown), Malika Kapadia, Deepak Chellapandian, Jennifer Whangbo, Rachael F. Grace, Chengyu Prince, Suhag Parikh, Robert A. Bray, Howard M. Gebel, Shanmuganathan Chandrakasan	1
4	Frequency of HLA-DR+CD38hi T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders 2023 ·Journal of Allergy and Clinical Immunology ·Thinh H. Nguyen, Deepak Kumar, Chengyu Prince, Dylan J. Martini, Jocelyn R. Grunwell, (unknown), (unknown), (unknown), Satheesh Chonat, Sampath Prahalad, Michael Briones, Shanmuganathan Chandrakasan	24
5	HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh 2022 ·Blood Advances ·Shanmuganathan Chandrakasan, Sharat Chandra, Chengyu Prince, Lisa Kobrynski, (unknown), Kiran Patel, Jolán E. Walter, Rebecca H. Buckley, Roland Meisel, Sujal Ghosh, Suhag Parikh	2
6	Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH) 2022 ·Journal of Allergy and Clinical Immunology ·Deepak Kumar, Christina A. Rostad, Preeti Jaggi, (unknown), Chengyu Prince, (unknown), Laila Hussaini, Thinh H. Nguyen, (unknown), Lori Ponder, (unknown), Evan J. Anderson, Michael Briones, Igñacio Sanz, Sampath Prahalad, Shanmuganathan Chandrakasan	26
7	mTOR inhibition attenuates cTfh cell dysregulation and chronic T-cell activation in multilineage immune cytopenias 2022 ·Blood ·Deepak Kumar, Thinh H. Nguyen, Carolyn M. Bennett, Chengyu Prince, (unknown), (unknown), (unknown), (unknown), (unknown), Edmund K. Waller, Sampath Prahalad, Michael Briones, Shanmuganathan Chandrakasan	10
8	HLA-DR+ CD38high Expression in T Cells Is Excellent in Quantifying the Amplitude of T-Cell Activation in a Spectrum of Hyperinflammatory Disorders Including HLH 2022 ·Blood ·Thinh H. Nguyen, Deepak Kumar, Chengyu Prince, Michael Briones, Shanmuganathan Chandrakasan	1
9	Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII 2021 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Chengyu Prince, (unknown), (unknown), Gabriela Denning, (unknown), Jaquelyn T. Zoine, H. Trent Spencer, Shanmuganathan Chandrakasan, Christopher B. Doering	8
10	Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells 2021 ·Gene Therapy ·Jaquelyn T. Zoine, Chengyu Prince, (unknown), (unknown), (unknown), Andrew Fedanov, (unknown), Christopher C. Porter, Christopher B. Doering, H. Trent Spencer, Shanmuganathan Chandrakasan	10
11	Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by UNC13D Genetic Defects 2020 ·Human Gene Therapy ·(unknown), (unknown), Andrew Fedanov, Chengyu Prince, Christopher B. Doering, H. Trent Spencer, Shanmuganathan Chandrakasan	18
12	Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome 2018 ·Clinical Immunology ·Oded Shamriz, Kiran Patel, Rebecca Marsh, (unknown), Avni Y. Joshi, (unknown), Chengyu Prince, (unknown), Lisa Kobrynski, Shanmuganathan Chandrakasan	12
13	Three charged amino acids in extracellular loop 1 are involved in maintaining the outer pore architecture of CFTR 2014 ·The Journal of General Physiology ·Guiying Cui, (unknown), Daniel T. Infield, (unknown), Chengyu Prince, Nael A. McCarty	24
14	Two Salt Bridges Differentially Contribute to the Maintenance of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel Function 2013 ·Journal of Biological Chemistry ·Guiying Cui, (unknown), (unknown), Chengyu Prince, (unknown), Nael A. McCarty	38
15	The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention 2010 ·Cancer Chemotherapy and Pharmacology ·(unknown), Harry W. Findley, Chengyu Prince, Anindya Dasgupta, Todd M. Cooper, Donald L. Durden	30
16	A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth 2007 ·Oncogene ·Gerene M. Denning, (unknown), Chengyu Prince, Donald L. Durden, Peter K. Vogt	88
17	Targeting PI3K in alveolar rhabdomyosarcoma (aRMS) 2006 ·Journal of Clinical Oncology ·Howland E. Crosswell, Qiong Peng, Chengyu Prince, Pradip De, Donald L. Durden	0
18	HRT1 modulates vascular smooth muscle cell proliferation and apoptosis 2003 ·Biochemical and Biophysical Research Communications ·Wenli Wang, Chengyu Prince, Xing Hu, Matthew J. Pollman	59
19	Notch3 Signaling in Vascular Smooth Muscle Cells Induces c-FLIP Expression via ERK/MAPK Activation 2002 ·Journal of Biological Chemistry ·Wenli Wang, Chengyu Prince, Yongshan Mou, Matthew J. Pollman	105
20	Coordinate Notch3-Hairy-related Transcription Factor Pathway Regulation in Response to Arterial Injury 2002 ·Journal of Biological Chemistry ·Wenli Wang, Alexandre Holthausen Campos, Chengyu Prince, Yongshan Mou, Matthew J. Pollman	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact